These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7888700)

  • 1. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
    Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
    Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice.
    Ashizawa T; Asada M; Kobayashi E; Okabe M; Gomi K; Hirata T
    Anticancer Drugs; 1993 Oct; 4(5):577-83. PubMed ID: 8292816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
    Levêque D; Jehl F; Quoix E; Monteil H
    Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
    Ashizawa T; Miyoshi K; Asada M; Kobayashi E; Okabe M; Morimoto M; Gomi K; Hirata T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):59-66. PubMed ID: 8422187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of KW-2170, a novel pyrazoloacridone derivative.
    Ashizawa T; Shimizu M; Gomi K; Okabe M
    Anticancer Drugs; 1998 Mar; 9(3):263-71. PubMed ID: 9625437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
    van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
    Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro.
    Sugiyama K; Shimizu M; Akiyama T; Ishida H; Okabe M; Tamaoki T; Akinaga S
    Br J Cancer; 1998 Jun; 77(11):1737-43. PubMed ID: 9667641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
    Adams DJ; Knick VC
    Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
    Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
    Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in vinca-alkaloids: Navelbine.
    Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose.
    Inaba M; Kobayashi T; Tashiro T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T
    Cancer; 1989 Oct; 64(8):1577-82. PubMed ID: 2507122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.
    Levêque D; Quoix E; Dumont P; Massard G; Hentz JG; Charloux A; Jehl F
    Cancer Chemother Pharmacol; 1993; 33(2):176-8. PubMed ID: 8261579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.
    Jones S; Winer E; Vogel C; Laufman L; Hutchins L; O'Rourke M; Lembersky B; Budman D; Bigley J; Hohneker J
    J Clin Oncol; 1995 Oct; 13(10):2567-74. PubMed ID: 7595708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
    Krikorian A; Breillout F
    Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine: a novel vinca alkaloid.
    Toso C; Lindley C
    Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
    Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
    Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.